Company
Cipla
Cipla has 15 drugs tracked on RxWires: 1 post-market, 7 approved, 6 in Phase 3, 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Generic HAART Triomune : d4T, 3TC, NVP | Post-Market | HIV |
| RITONAVIR | Approved | |
| RIFAXIMIN | Approved | |
| DEFERASIROX | Approved | |
| ENTECAVIR | Approved | |
| TAVABOROLE | Approved | |
| DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | Approved | |
| MELOXICAM | Approved | |
| Fluticasone propionate/salmeterol 100/50 µg | Phase 3 | Bronchial Asthma |
| Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg | Phase 3 | Asthma |
| 90 mcg Reference Product | Phase 3 | Bronchial Asthma |
| Misoprostol | Phase 3 | Postpartum Hemorrhage |
| Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation) | Phase 3 | Bronchial Asthma |
| CBT124 | Phase 3 | Non-Small Cell Lung Carcinoma |
| Plazomicin Injection | Phase 1 | End Stage Renal Disease |
Latest
Follow Cipla on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.